Cargando…
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
Animal models have contributed significantly to our understanding of the underlying biological mechanisms of Alzheimer's disease (AD). As a result, over 300 interventions have been investigated and reported to mitigate pathological phenotypes or improve behavior in AD animal models or both. To...
Autores principales: | Shineman, Diana W, Basi, Guriqbal S, Bizon, Jennifer L, Colton, Carol A, Greenberg, Barry D, Hollister, Beth A, Lincecum, John, Leblanc, Gabrielle G, Lee, Linda (Bobbi) H, Luo, Feng, Morgan, Dave, Morse, Iva, Refolo, Lorenzo M, Riddell, David R, Scearce-Levie, Kimberly, Sweeney, Patrick, Yrjänheikki, Juha, Fillit, Howard M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218805/ https://www.ncbi.nlm.nih.gov/pubmed/21943025 http://dx.doi.org/10.1186/alzrt90 |
Ejemplares similares
-
Novel strategies for the prevention of dementia from Alzheimer's disease
por: Shineman, Diana W., et al.
Publicado: (2009) -
Meeting the unique challenges of drug discovery for neurodegenerative diseases
por: Shineman, Diana W, et al.
Publicado: (2009) -
A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USA
por: Lee, Linda H, et al.
Publicado: (2010) -
Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementias
por: Lane, Rachel F, et al.
Publicado: (2011) -
Evidence that Enzyme Processivity Mediates Differential Aβ Production by PS1 and PS2
por: Pintchovski, Sean A, et al.
Publicado: (2013)